Key Takeaways
- • Vivian Health secures $60 million in primary and secondary equity funding led by Thoma Bravo, with participation from parent company IAC and Collaborative Fund, to accelerate growth and fund future M&A initiatives.
- • The healthcare jobs marketplace has reached significant scale in five years, facilitating 15% of U.S. travel nursing placements ($1.5 billion in annualized labor spend) with over 700,000 registered clinicians on its platform.
- • Vivian's employer network spans 145+ healthcare organizations, including staffing agencies and health systems, achieving 50% faster job placement and up to 80% cost reduction compared to alternative solutions.
- • The funding capitalizes on a structural market tailwind: the U.S. healthcare sector faces a projected shortage of 3 million workers by 2026, driving demand for efficient talent marketplace solutions.
- • As an IAC subsidiary, Vivian Health joins a portfolio of digital consumer and marketplace platforms; the Thoma Bravo investment signals institutional confidence in software-driven healthcare staffing platforms.
Summary
Vivian Health, the healthcare jobs marketplace owned by IAC, announced a $60 million investment round led by private equity firm Thoma Bravo on April 26, 2022. The funding round included participation from parent company IAC and venture firm Collaborative Fund, and combines both primary and secondary equity components. The capital will be deployed to accelerate organic growth, expand scale among healthcare professionals and employers, and fund future acquisition activity.
In five years of operation, Vivian Health has established itself as a dominant player in the healthcare staffing marketplace. The platform serves over 700,000 registered healthcare clinicians seeking employment and partners with more than 145 healthcare employers, including staffing agencies and integrated health systems. The company has captured approximately 15% of U.S. travel nursing placements, representing $1.5 billion in annualized labor spend. Much of this growth has occurred through organic adoption and word-of-mouth referrals rather than paid acquisition channels.
Healthcare employers using Vivian's platform report material operational improvements: jobs are filled up to 50% faster than through competing solutions, and total hiring costs decline by up to 80%. These performance metrics reflect the value proposition of a purpose-built marketplace serving healthcare professionals first, offering employers access to permanent roles, per-diem shifts, local contracts, and travel positions through a single integrated platform.
The timing of this funding aligns with structural workforce imbalances in the U.S. healthcare sector. Industry forecasts indicate a shortage of more than 3 million healthcare workers by 2026, creating sustained demand for efficient talent-matching platforms. Thoma Bravo's participation underscores institutional validation of software-driven healthcare staffing solutions; the firm is an established investor in enterprise software and healthcare technology platforms. The investment provides Vivian Health with capital flexibility to pursue both organic expansion and strategic M&A opportunities, positioning the company to capture an expanding share of the healthcare labor market during a period of acute worker shortage.
In five years of operation, Vivian Health has established itself as a dominant player in the healthcare staffing marketplace. The platform serves over 700,000 registered healthcare clinicians seeking employment and partners with more than 145 healthcare employers, including staffing agencies and integrated health systems. The company has captured approximately 15% of U.S. travel nursing placements, representing $1.5 billion in annualized labor spend. Much of this growth has occurred through organic adoption and word-of-mouth referrals rather than paid acquisition channels.
Healthcare employers using Vivian's platform report material operational improvements: jobs are filled up to 50% faster than through competing solutions, and total hiring costs decline by up to 80%. These performance metrics reflect the value proposition of a purpose-built marketplace serving healthcare professionals first, offering employers access to permanent roles, per-diem shifts, local contracts, and travel positions through a single integrated platform.
The timing of this funding aligns with structural workforce imbalances in the U.S. healthcare sector. Industry forecasts indicate a shortage of more than 3 million healthcare workers by 2026, creating sustained demand for efficient talent-matching platforms. Thoma Bravo's participation underscores institutional validation of software-driven healthcare staffing solutions; the firm is an established investor in enterprise software and healthcare technology platforms. The investment provides Vivian Health with capital flexibility to pursue both organic expansion and strategic M&A opportunities, positioning the company to capture an expanding share of the healthcare labor market during a period of acute worker shortage.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.